Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin D Boyd

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Biomolecular Screening|September 11, 2013
A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicityJustin D Boyd, Peter Lee, Marisa S Feiler, et al.
Mbio|February 16, 2012
A new means to identify type 3 secreted effectors: functionally interchangeable class IB chaperones recognize a conserved sequenceSonia C P Costa, Alexa M Schmitz, Fathima F Jahufar, et al.
Frontiers in Cellular Neuroscience|June 9, 2022
GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer's DiseaseSarah M Connor, Mamunur Rashid, Katie J Ryan, et al.
Neurobiology of Disease|December 17, 2017
Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neuronsJason Schapansky, Saurabh Khasnavis, Mark P DeAndrade, et al.
Cell Reports|August 25, 2015
Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and Neural Cell FatePriya Srikanth, Karam Han, Dana G Callahan, et al.
Plos One|March 3, 2010
Angiogenic factors stimulate growth of adult neural stem cellsAndreas Androutsellis-Theotokis, Maria A Rueger, Deric M Park, et al.
Journal of Lipid Research|January 12, 2024
VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeysMadeline M Vroom, Hanxin Lu, Maggie Lewis, et al.
Communications Medicine|April 29, 2025
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D Boyd, Shixia Wang, Hsiao-Wen Lin, et al.
Science Translational Medicine|December 22, 2017
A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variantsKatie J Ryan, Charles C White, Kruti Patel, et al.
Nature Medicine|June 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Biomolecular Screening|September 11, 2013
A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicityJustin D Boyd, Peter Lee, Marisa S Feiler, et al.
Mbio|February 16, 2012
A new means to identify type 3 secreted effectors: functionally interchangeable class IB chaperones recognize a conserved sequenceSonia C P Costa, Alexa M Schmitz, Fathima F Jahufar, et al.
Frontiers in Cellular Neuroscience|June 9, 2022
GW5074 Increases Microglial Phagocytic Activities: Potential Therapeutic Direction for Alzheimer's DiseaseSarah M Connor, Mamunur Rashid, Katie J Ryan, et al.
Neurobiology of Disease|December 17, 2017
Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neuronsJason Schapansky, Saurabh Khasnavis, Mark P DeAndrade, et al.
Cell Reports|August 25, 2015
Genomic DISC1 Disruption in hiPSCs Alters Wnt Signaling and Neural Cell FatePriya Srikanth, Karam Han, Dana G Callahan, et al.
Plos One|March 3, 2010
Angiogenic factors stimulate growth of adult neural stem cellsAndreas Androutsellis-Theotokis, Maria A Rueger, Deric M Park, et al.
Journal of Lipid Research|January 12, 2024
VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeysMadeline M Vroom, Hanxin Lu, Maggie Lewis, et al.
Communications Medicine|April 29, 2025
Preclinical characterization of an active immunotherapy targeting calcitonin gene-related peptideJustin D Boyd, Shixia Wang, Hsiao-Wen Lin, et al.
Science Translational Medicine|December 22, 2017
A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variantsKatie J Ryan, Charles C White, Kruti Patel, et al.
Nature Medicine|June 20, 2024
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Pinaki Misra, Luis Concha-Marambio, et al.
Pageof 3